NIVOLUMAB-INDUCED MYASTHENIA GRAVIS WITH MYOCARDITIS AND MYOSITIS

被引：0
|
作者：
Tamkus, Greta
Boucekkine, Houda
Seibert, Katherine
Eng, Kevin
Betancourt, Jaime
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.2779
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4268A / 4269A
页数：2
相关论文
共 50 条
  • [41] Pembrolizumab-induced Myasthenia Gravis and Myocarditis
    Won, Jisun
    Zhao, Edward
    States, Melissa
    Brown, Rachel
    El-habr, Abdallah
    Damsker, Jason
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2024, 14 (03):
  • [42] TRIPLE-M (MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS) SYNDROME IN A PATIENT RECEIVING NIVOLUMAB: A CARDIO-ONCOLOGIC EMERGENCY
    Golec, Sophia
    Mitrani, Lindsey
    Yoon, Joseph
    Dangayach, Neha
    Sahni, Gagan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3459 - 3459
  • [43] ACUTE RIGHT HEART FAILURE SECONDARY TO NIVOLUMAB-INDUCED MYOCARDITIS
    Alghothani, Y.
    Alghothani, L.
    Amin, E.
    CHEST, 2019, 155 (04) : 90A - 90A
  • [44] Myocarditis in myasthenia gravis
    Finsterer, Josef
    Stoellberger, Claudia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 342 - 343
  • [45] 3M syndrome (myasthenia, myositis, myocarditis) related to nivolumab treatment
    Rouby, F.
    Polard, E.
    Pietri, T.
    Laugier, D.
    Micallef, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 13 - 14
  • [46] Nivolumab/relatlimabMyocarditis, myositis and myasthenia gravis-like syndrome: case report
    Reactions Weekly, 2025, 2052 (1) : 330 - 330
  • [47] Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review
    Siu, Derrick Ho Wai
    O'Neill, Robert Sean
    Harris, Carole A.
    Wang, Justine
    Ardolino, Luke
    Downton, Teesha
    Tong, Matthew
    Hong, Jun Hee
    Chin, Venessa
    Clingan, Philip R.
    Aghmesheh, Morteza
    Soudy, Hussein
    IMMUNOTHERAPY, 2022, 14 (07) : 511 - 520
  • [48] Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single-center case series
    Longinow, Joshua
    Zmaili, Mohammad
    Skoza, Warren
    Kondoleon, Nicholas
    Marquardt, Robert
    Calabrese, Cassandra
    Funchain, Pauline
    Moudgil, Rohit
    CANCER MEDICINE, 2023, 12 (03): : 2281 - 2289
  • [49] IMMUNE CHECKPOINT INHIBITOR-RELATED MYASTHENIA GRAVIS, MYOSITIS, HEPATITIS, AND MYOCARDITIS
    Pham, Phuoc
    Heppler, Miranda
    Jackson, Ian P.
    Plambeck, Robert W.
    CHEST, 2024, 166 (04) : 5381A - 5382A
  • [50] Multiple drugsFatal myasthenia gravis, myocarditis and myositis, and lack of efficacy: case report
    Reactions Weekly, 2022, 1895 (1) : 267 - 267
12345